×

New Regulations on Alcohol-Containing Medicines to Combat Misuse

The Indian government has introduced new regulations to combat the misuse of alcohol-containing medicines. By placing oral formulations with over 12% ethyl alcohol under stricter oversight, the Ministry of Health aims to enhance public health safety. This move addresses concerns regarding the misuse of cough syrups and other medicinal products with high alcohol content. The revised rules will come into effect six months after their official publication, marking a significant step in strengthening the regulatory framework for pharmaceuticals in India. Stay informed about how these changes will impact the availability and regulation of such medicines.
 

New Delhi Implements Stricter Rules for Alcohol-Based Medicines

New Delhi: In a significant move to curb the misuse of medications containing alcohol, the Indian government has updated the Drugs Rules of 1945. This revision categorizes all oral formulations with over 12% ethyl alcohol, packaged in bottles larger than 30 ml, under Schedule H1. The Union Ministry of Health and Family Welfare announced this change through a gazette notification on Wednesday (July 8). This decision aims to address the misuse of certain cough syrups and other oral medications that have elevated alcohol levels. The ministry stated, "To enhance regulatory oversight and prevent the misuse of medicinal products with high alcohol content, the Ministry of Health and Family Welfare has eliminated the previous exemption from licensing requirements for ethyl alcohol-containing formulations under Schedule K." By placing these products under Schedule H1, which necessitates stricter regulation, the government intends to reduce misuse, encourage responsible dispensing, and enhance pharmacovigilance.

Implementation Timeline for New Regulations

The revised regulations will be referred to as the Drugs (Tenth Amendment) Rules, 2026, and will take effect six months after their publication in the Official Gazette.